Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe + Fenofibrate vs Pravastatin in HIV Patients With Hyperlipidemia
NCT00843661Phase 4Unknown
- Sponsor
- ASST Sette Laghi
- Start
- Mar 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ezetimibe and fenofibrate in hyperlipidemia (2 arms), sponsored by ASST Sette Laghi. Primary endpoint: Per cent changes of LDL cholesterol at 6 months. Status: unknown.
02
Drugs
ezetimibefenofibrate
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT00843661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00843661.